Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01988350 · ClinicalTrials.gov registry record
Pancreatic Insufficiency Secondary to Tobacco Exposure
A clinical trial, sponsored by Emory University.
- Completed
- Registry status
- 202
- Enrollment target
NCT01988350 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 202 participants.
The verdict
NCT01988350 has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 202 participants
- Enrollment target
Study Summary
Pancreatic insufficiency is a condition in which there is a decrease in the production and release of enzymes made in the pancreas, which causes nutrient malabsorption. There are many chronic diseases that can lead to pancreatic insufficiency. In the early stages of this disease, a patient may not experience any symptoms, and the prevalence of pancreatic insufficiency may be underestimated. Smoking has long been recognized as a cause of disease in many organs in the body. Cigarette smoke causes inflammation and damages tissue, including the pancreas. Studies have shown that smoking is an independent risk factor for pancreatic cancer and chronic pancreatitis. It has also been shown that the more a person smokes, the worse his disease will be. Additionally, there are studies that show that smokers have nutritional deficiencies. There are observational and retrospective studies that suggest that pancreatic insufficiency may also be caused by smoking. However, this has not been established, and the relationship has not been examined in a controlled manner. This study examines the relationship between smoking and pancreatic insufficiency in patients who do not have other pancreatic diseases.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 202 participants |
| Start Date | 2013-05 |
| Est. Completion | 2013-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01988350
The ClinicalTrials.gov registry entry for NCT01988350 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 202 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01988350 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01988350 about?
NCT01988350 is a clinical study titled "Pancreatic Insufficiency Secondary to Tobacco Exposure". Pancreatic insufficiency is a condition in which there is a decrease in the production and release of enzymes made in the pancreas, which causes nutrient malabsorption. There are many chronic diseases that can lead to pancreatic insufficiency. In the early stages of this disease, a patient may not e...
What is the current status of trial NCT01988350?
This trial is currently completed. The enrollment target is 202 participants. The study started on 2013-05. Estimated completion is 2013-08.
Who is sponsoring clinical trial NCT01988350?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.